← Back to list
Oakmark FundsQuarterly31 Dec 2021Source: oakmark.com

Oakmark Fund: Fourth Quarter 2021

Oakmark is the mutual fund family launched in 1991 by Harris Associates, the Chicago deep-value firm founded in 1976 (about $105bn AUM). Bill Nygren runs the flagship Oakmark Fund and David Herro the Oakmark International Fund, buying businesses at large discounts to intrinsic value and holding them like owners — publishing quarterly fund commentaries, market commentaries and insight articles.

Bill Nygren、David Herro · 1991 · 美国芝加哥Deep value / contrarian long-term

In plain words

This report shows how the Oakmark Fund performed through late 2021. Since starting in 1991, it averaged 13.15% annual returns. Over the past 10 years, it averaged 15.65% per year, and in 2021 alone it jumped 34.20%. Its fees (expense ratio) are low at 0.91%. For regular investors, this means a good fund can grow money over time, but a 34% gain in one year is unusual and won't repeat. Also, the low fees are temporary—they may rise after January 2022, so watch out.

AI SummaryAI-generated · may contain errors · verify against the original

Oakmark Fund (Investor Class) reported its performance as of December 31, 2021: annualized return of 13.15% since inception on August 5, 1991, 15.65% over 10 years, 15.26% over 5 years, 34.20% over 1 year, and 4.73% over 3 months. The gross expense ratio is 0.93%, and the net expense ratio is 0.91%,

~2 min full read · 5 sections
Deep Analysis

Theme and Background

This section summarizes the performance and expense data of the Oakmark Fund (Investor Class) as of December 31, 2021, showcasing the fund's long-term return track record since its inception in 1991 and its current fee structure.

Core Thesis

The report's implicit core investment thesis is that the Oakmark Fund has delivered solid annualized returns over the long term (since its inception in 1991) and medium term (10 years, 5 years), with particularly strong short-term 1-year returns (34.20%) and a low expense ratio (net expense ratio of 0.91%). This indicates the fund's ability to consistently generate excess returns while controlling costs.

Key Arguments and Data

  • Stable Long-Term Returns: Since its inception on August 5, 1991, the annualized return stands at 13.15%, reflecting significant 30-year compound growth.
  • Strong Medium-Term Performance: The 10-year annualized return is 15.65%, and the 5-year annualized return is 15.26%, both exceeding the long-term average, suggesting the effectiveness of recent strategies.
  • Short-Term Momentum: The 1-year return of 34.20% far exceeds the long-term average, potentially benefiting from market style or portfolio concentration.
  • Low Expense Ratio: The gross expense ratio is 0.93%, and the net expense ratio is 0.91% (due to an advisory fee waiver agreement effective until January 27, 2022), below the industry average for actively managed funds.
Time Period Annualized Return
Since Inception (1991/08/05) 13.15%
10 Years 15.65%
5 Years 15.26%
1 Year 34.20%
3 Months 4.73%
Expense Type Ratio
Gross Expense Ratio 0.93%
Net Expense Ratio (with Waiver) 0.91%

Companies/Assets Involved

  • Oakmark Fund (Investor Class): The subject of the report; no specific portfolio holdings are mentioned. The report only presents the fund's overall performance without making bullish or bearish judgments on individual stocks.

Investment Implications

  • Long-Term Holding Strategy is Effective: The fund's 30-year annualized return of 13.15% suggests that adhering to value investing or active management strategies can outperform inflation and generate substantial returns over the long term.
  • Monitor Expense Waiver Expiration Risk: The net expense ratio of 0.91% relies on an advisory fee waiver agreement valid until January 27, 2022. After expiration, expenses may revert to 0.93%, and investors should assess the impact of rising costs on net returns.
  • Short-Term High Returns Are Unsustainable: The 1-year return of 34.20% far exceeds the long-term average. Investors should not view this as the norm and must be cautious of mean reversion risk.